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Summary Clustering oftesticular cancer cases in families is well known, although the aetiology is not. We present the results of asegregation
analysis performed with the algorithm Pointer on familial data on 978 Scandinavian patients with testicular cancer. The segregation analysis
favoured the involvement of major gene effects over models incorporating solely polygenic effects in testicular cancer aetiology. Overall, a
recessive model best fits the family observations with an estimated gene frequency of 3.8% and a lifetime risk for homozygous men of
developing the disease of 43%. This implies that 7.6% of men in the general population will be carriers ofthe mutant allele and that 0.1% would
be homozygote and are, therefore, at high risk of developing the cancer. The testicular cancer incidence has changed greatly during the last
generation. Also, the lethality of the disease has changed because of the introduction of new therapy. As failure to take account of such time
trends might lead to inappropriate evidence for a recessive model, the analyses were repeated under different assumptions. The analyses
favoured a recessive model of inheritance under all assumptions tested. However, the assumptions underlying the analyses are complex and,
as this is the first segregation analysis of testicular cancer, the results must be interpreted cautiously.
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Segregation analysis is a statistical technique which attempts to
explain the causes offamily aggregation of disease (Morton et al,
1983). Basically, a major gene, polygenes and unmeasured envi-
ronmental exposures are assumed to contribute to susceptibility to
disease and, on the basis ofthe observed pattern ofdisease within
families, different explanations of the family aggregation are
compared. The technique is most informative when the family
material consists of the relatives of a systematically collected
series ofcases from a population-based register. Such studies have
resulted in the identification of putative major gene effects for
susceptibility to cancer at several sites, including the breast (e.g.
Claus et al, 1991), ovary (Houlston et al, 1991) and bowel
(Houlston et al, 1995). These results have been verified at least in
part by the successful linkage mapping ofgenes that contribute to
the susceptibility (Hall et al, 1990; Peltomaki et al, 1993).
Testicular germ cell cancer is widely believed to be caused
mainly by environmental factors operating in utero or in early
childhood (Oliver, 1990). However, familial clustering is well
known, and there is an increased relative risk for male first-degree
relatives oftesticular cancer cases. The relative risk to brothers has
been estimated to be as high as 6-10 (Tollerud et al, 1985; Forman
et al, 1992; Goldgar et al, 1994; Heimdal et al, 1996). This is
higher than for most common cancers studied and highlights the
probable importance of genetic factors in disease causation
(Cannon-Albright et al, 1991). In contrast to published multicase
families for the common cancers, families usually have only two
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members affected by testicular cancer, and simple inspection of
the pedigrees is not sufficient to establish the mode ofinheritance.
Two factors complicate the interpretation of the incidence of
familial testicular tumours. Firstly, the incidence rates oftesticular
cancer have changed greatly and, secondly, treatment has changed
the lethality of the disease during the last generation (Oliver,
1990). In the parental generation (before 1960 approximately),
there was essentially no effective treatment for metastatic testic-
ular cancer, and the fertility of the group of affected individuals
would be greatly reduced. Thus, men with testicular cancer diag-
nosed before 1960 would be less likely to produce offspring or,
equivalently, the sons born in the 1960s would be less likely to
have an affected parent than would be predicted on the basis of
population rates. Subsequently, probands (ascertained during the
1980s) were given effective multimodal treatment. This group
therefore has only marginally reduced fertility. These two factors
present appreciable complications to a segregation analysis of
testicular cancer.
We present the results of the first segregation analysis oftestic-
ular cancer. This analysis, using the software Pointer, is based on
the families of978 Scandinavian patients treated at the Norwegian
Radium Hospital and in Lund, Sweden, over a 10-year period.
MATERIALS AND METHODS
Ascertainment of families
The family material on which the segregation analysis was based
consisted of the relatives of all available patients treated at the
Norwegian Radium Hospital and in Lund for testicular germ cell
tumourfrom 1981-91 as described elsewhere (Heimdal etal, 1996).
The two institutions are responsible for the post-orchiectomy
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Table 1 The definition of the five liability classes assumed in the segregation analysis and the corresponding estimated cumulative incidence of testicular
cancer to midpoint of the age interval (columns 1-2). The cumulative incidence has been calculated from population incidences of testicular cancer in Norway
(see text). The estimated penetrances from segregation analysis are also given in this table (columns 3-4). These penetrances also relate to the midpoint of the
specified agent force
Definition of liability class Cumulative incidence Recessive Heterozygote/homozygote
to midpoint susceptible normal
1. Proband generation: men aged 15-34 0.00150 0.27 0.0011
2. Proband generation: men aged 35-54 0.00390 0.39 0.0034
3. Proband generation: men aged 55 and above 0.00530 0.43 0.0047
4. Parental generation: men aged 35-54 0.00120 0.24 0.0009
5. Parental generation: men aged 55 and above 0.00190 0.29 0.0015
treatment of all testicular cancer in their catchment areas. Family
history was collected through a questionnaire-based survey of the
patients. All patients treated atthetwo institutions during this period
who were alive and could be located were invited to complete the
questionnaire asking for information on testicular cancer in their
first-degree relatives, the ages ofonsetforcases and current ages for
unaffected relatives.
Eighty-four per cent (978 out of 1159 patients) of the patients
returned questionnaires with family information. The majority of
patients about whom no family information was available had died
before this study was conducted. Testicular cancer in a first-
degree relative was reported by 30 patients (Heimdal et al, 1996).
All diagnoses oftesticular germ cell tumour in probands and rela-
tives have been verified in the Norwegian or Swedish Cancer
Registries and/or by histological reports. From the 978 probands,
five fathers and two father-son pairs (doubly ascertained) and 17
brother-brother pairs, six of which were doubly ascertained, were
found to be affected with testicular cancer. In the analyses
conducted here, no family had more than two affected individuals.
Statistical analysis
Segregation analysis was performed using the software Pointer
(Lalouel and Morton, 1981). Pointer assumes the mixed model of
inheritance, that is, segregation is explained by a major gene, a
polygenic background and unmeasured environmental exposures.
The effects of these factors are assumed to be additive on the
liability scale. Pointer does not allow for the joint analysis of the
ascertained families but rather considers an extended pedigree as
being made up of its nuclear family components. These nuclear
families are related to the extended pedigree by conditioning on
their relatedness to each other.
The parameterization of the mode of inheritance takes advan-
tage ofthe major assumption ofthe model, which is that all factors
act on the liability scale. For the major gene component, the model
assumes two alleles at a single locus (A, a) withA being associated
with increased risk of testicular cancer. Individuals with an 'aa'
genotype are assumed (without loss ofgenerality) to have a value
of 0 on the liability scale, while the disease-associated homozy-
gote has a value of t (> 0) and the heterozygote d*t. For the
heterozygote to have an effect on penetrance that is intermediate
between the two homozygotes, d is constrained by 0 < d < 1. The
allele frequency of A is q, and Hardy-Weinberg equilibrium is
assumed. Finally, the residual polygenic heritability is modelled
by H, the proportion ofvariance around these values for the major
genes which is determined by polygenic inheritance under the
assumption that deviations from the stated values for the major
gene component are normally distributed. These assumptions are
sufficient to define the threshold value T for the liability so that
any male whose liability exceeds T is affected with testicular
cancer. Tis estimated for a given set of parameter values from the
cumulative incidence rate oftesticular cancer.
As both hospitals in this study treat all cases diagnosed in their
geographical regions, families with the proband as a child were
coded for Pointer as having ascertainment with a high value of n,
the ascertainment probability. There were 970 such families, seven
of them with an affected parent. The families with the proband as
parent were coded as complete ascertainment, that is their ascer-
tainment followed directly after the identification of the proband.
There were 454 such families with 2697 children.
In an attempt to accommodate the complicating factors of
changing fertility (through treatment improvements) and inci-
dence, men were classified to one of five liability classes
depending on their generation within the pedigree (proband gener-
ation vs parent ofproband generation) and their current age or age
at testicular cancer onset [15-34 years of age (proband generation
only), 35-54 years of age and greater than 54 years of age] (see
Table 1). Allowing for different liability classes by generation
should accommodate the changing rates oftesticular cancer on the
population level. Cumulative incidence rates forthese five liability
classes were calculated on the basis of published 10-year inci-
dence rates for testicular cancer in Norway during 1982-91 (Table
1). The lack of registry data for the previous generations further
complicates the assessment of cumulative incidence rates for the
liability classes of the parental generation. To circumvent this
problem, the analyses were repeated assuming that incidence rates
in the parental generation were one-third of, one-halfof and equal
to the 1982-91 incidence rates. The extremes ofthese assumptions
are thought to cover the range of incidence rates since cancer
registration began in the 1950s. At that time, there were approxi-
mately one-third the reported number ofcases of testicular cancer
annually compared with current times. These assumptions allow
the estimation of a separate threshold T for each liability class.
Women and men under the age of 15 years were coded to indicate
their lack ofpredisposition to testicular cancer.
To allow for the effect of parental disease on fertility, fathers of
probands were assumed to be not at risk oftesticular cancer before
the age of 35 years. There were no such fathers in the sample and
the youngestdiagnosis in a father was 36 years ofage. Fathers were
assumed to have incidence rates oftesticular cancer identical to the
general population after age 35 years as the majority of their
offspring would have been born before that age. Analyses were
conducted conditional on parental disease status in a further effort
to compensate forfertility differences in affected men.
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Table 2 The comparison of likelihoods under the mixed model with the
estimated parameters under that model. Parameter values in parentheses
are fixed at that value under that assumed model. The log-likelihood
difference is based on comparisons with the mixed model for which all
components are included in the model
Model d t q H 2 * Ln difference
Complete 0.0 2.42 0.038 0.00 -
Recessive major gene (0.0) 2.42 0.038 (0.0) 0.00
Dominant major gene (1.0) 1.60 0.003 (0.0) 5.18
Additive major gene (0.5) 2.08 0.07 (0.0) 4.54
Polygenic - - - 0.43 7.16
Sporadic - - - - 38.51
Analyses were also repeated for a range of values of t with the
ascertainment probability from 0.4 to 0.9. Varying t did not have
substantial effects on the results (data not shown). Analyses
reported here are computed with a value of t of0.52, which is the
estimated value of n when there are 17 brother-brother pairs, six
of which are doubly ascertained (Morton et al, 1983).
RESULTS
Table 2 shows the results of the segregation analysis assuming that
the parents of probands had incidence rates one-half of that of the
proband generation. Segregation analysis suggests that a recessive
model best fits the collected families (Table 2). For comparison of
models, we report twice the natural logarithm difference between
the model under consideration and the complete model, that is the
model with the major gene and polygenic components being
jointly estimated from the total dataset and other assumed models.
For the complete model, the estimate of the polygenic heritability
was zero while the major gene model favoured a recessive gene.
Among the major gene models, a recessive model had a value of
twice the natural logarithm greater than 4.5 more than the value for
either the dominant or an additive model in which heterozygotes
had intermediate penetrance between that of each of the two
normal homozygotes. A purely polygenic model had a value of
twice the natural logarithm of 7.16 less than the recessive model.
For the comparisons given in Table 2, the recessive model there-
fore was considered parsimonious.
Under this recessive model the estimated gene frequency was
3.8% (Table 2). This implies that 7.6% of the men would be
carriers of such a mutant allele but only those who were homozy-
gotes would be at high risk of testicular cancer. Under this model,
homozygote men would have a 43% lifetime risk of developing
testicular cancer. Furthermore, about 25% of testicular cancer
cases diagnosed before the age of 35 years in the proband genera-
tion would be attributed to this susceptibility, 14% of cases
between 35 and 54 years and 12% after the age of 55 years. For the
parental generation, the susceptibility would explain slightly
higher proportions of all cases (because the population incidence
rates were lower), i.e. 29% of cases between 35 and 54 years and
22% of cases above the age of 55 years.
One possible explanation of a recessive mode of inheritance is
that the difference in incidence rates is not well modelled by our
assumption that the parental generation has incidence rates of one-
half of the proband generation. We therefore repeated the analysis
assuming that the incidence rates had not changed over time.
Although this latter assumption does not seem feasible in the light
of the number of cases reported to the cancer registries, it does
allow an extreme analysis ofthe role of inherited susceptibility. In
fact, under this assumption, a recessive model is still the most
plausible explanation with an estimated frequency ofthe suscepti-
bility mutation of 0.033 and a lifetime risk of testicular cancer of
49%. Model comparisons are similar to those presented here
except that the distinction between the recessive models and the
others is increased (to, for instance, 5.80 overthe dominant model)
in keeping with the failure to take into account the trend in inci-
dence rates. At the other extreme, when the rates in the parental
generation are one-third of those in the proband generation, the
estimated frequency of the susceptibility allele is 0.035 with an
associated lifetime risk of46%. In summary, therefore, as varying
the assumptions about the relative incidence oftesticular cancer in
parental and proband generations within reasonable limits did not
appreciably change the best fitting models or the model compar-
isons, these particular estimates seem quite robust.
Analyses conducted with different values of u produced only
marginally different recessive models and had similar results to
those given in Table 2 for model comparisons (data not shown).
DISCUSSION
As this is the first segregation analysis of testicular cancer, the
results should be verified in other data sets. Our analysis is based
on more than one-halfofthe total number ofcases seen in Norway
and all cases seen in Southern Sweden during the period in which
modern treatment has been curing the great majority of testicular
cancer patients. Analyses are required on data sets from other
populations to compare with the findings here, especially as the
scarcity ofmultiple-case families reduces the ability to distinguish
between modes of inheritance in segregation analysis.
Segregation analysis favours the involvement of major gene
effects in testicular cancercausation. Ouranalyses are in favourofa
recessive mechanism; this conclusion seemsjustified in light ofthe
lack ofvariation in the estimates ofthe model parameters when the
frequency oftesticular cancer was varied in the parental generation.
The results are in support of major gene models over models
incorporating polygenic effects only. The analysis favours reces-
sive gene models, and there are indications that testicular cancer
may be the first common cancer caused by a relatively common
recessive gene, possibly in combination with polygenic-environ-
mental effects operating predominantly in recent generations.
Nicholson and Harland (1995), using a different approach and
analysis from the current work, also favour a recessive gene that is
responsible for one-third of testicular cancer cases. This is some-
what higher than our estimates. However, their estimate of the
gene frequency (5%) is similar to ours using the recessive model
(3.6%). Furthermore, they estimate the penetrance to be 45%.
Their analysis is based on the frequency of bilateral to unilateral
tumours and takes into account information that is not used here.
Their conclusions should therefore be regarded as independent
support for a recessive mechanism.
There are at least four studies showing the relative risk to
brothers to be between 6 and 10 (Tollerud et al, 1985; Forman et al,
1992; Goldgar et al, 1994; Heimdal et al, 1996). Because of
methodological difficulties, especially concerning the lethality of
the disease and the resulting lack of fitness of affected individuals
in former generations combined with the lack of reliable cancer
registries before 1950, the estimates of risk to fathers have wider
confidence limits.Published studies do,however,indicatethat the
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increase in relative risk is greater in brothers than in fathers of
testicular cancer cases (Heimdal et al, 1996). This finding is also
consistent with a recessive model ofinheritance.
The ability to identify genes that predispose to testicular cancer
is determined by the true mode ofinheritance, the number ofgenes
involved and their relative frequencies and penetrance. Segregation
analysis cannot distinguish between one and more than one major
gene. However, if a single gene were involved then the magnitude
of the increased risk to first-degree relatives indicates that such a
gene should be readily mapped (Risch, 1990). In the first major
effort to map such a gene, brothers with testicular cancer have been
identified and sampled and then a genomic search was performed
(Leahy et al, 1995). Evidence for a number of genetic regions has
been shown but no one region is unequivocally the site of a testis
cancer gene. It is of note, however, that for the regions with the
highest LOD scores, evidence for linkage was strongest under
recessive models. This mustbe taken into account in further genetic
studies ofthis disease. Ourresults also illustrate that most testicular
cancer is caused by other factors than major genes (polygenes and
environmental factors) and emphasizes the importance of environ-
mental factors in disease causation. Thus, the present data are in
keeping with the marked increase in testicular cancer incidence
rates over the past generation, which cannot be due to genetic
factors alone.
Segregation analyses in other familial cancer syndromes (familial
breast, breast-ovarian, HNPCC and Li Fraumeni syndromes) have
indicated the involvement of rare dominant alleles (Claus et al,
1991; Houlston et al, 1995). Also, in ataxia telangiectasia, even
though the syndrome is caused by the homozygous (recessive)
genotype, cancer risk is increased both in homozygotes and
heterozygotes (Swift et al, 1991). The current analysis cannot
soundly reject the hypothesis that testicular cancer fits the general
concept of genetic cancer caused by a very rare, dominant allele
(Table 2). The difference, when comparing testicular cancer with
other genetic cancers using the dominant model, is that the testis
cancer causing allele has very low penetrance. Thus testicular
cancer is usually not familial. However, we cannot reject the
hypothesis that testicular cancer may be the first relatively common
cancer discovered to be caused by a fairly common recessive allele.
In summary, segregation analysis supports the contention that
testicular cancer is due to a recessive gene. One major concem
about this analysis is the issue of time trends in testicular cancer
rates, i.e. changing lethality ofthe disease and changing fertility of
males with testicular cancer. Inappropriate accounting for such
trends might lead to inappropriate evidence for a recessive model.
We have investigated this and have found that modifying assump-
tions about testicular cancer rates does make a minor difference to
the evidence for the recessive model of inheritance. However, for
each different set ofassumptions, a recessive model seems to offer
the most reasonable explanation for the clustering of testicular
cancer cases in families.
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